Blueprint Medicines (BPMC) came out with a quarterly loss of $0.80 per share versus the Zacks Consensus Estimate of a loss of$1.28. This compares to loss of $2.19 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 37.50$1.64 per share when it actually produced a loss of $1.32, delivering a surprise of 19.51%.Over the last four quarters, the co ...